Adicet Bio, Inc. Increase (Decrease) in Construction Payables
Adicet Bio, Inc. (ACET) reported Increase (Decrease) in Construction Payables of $8.80 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInConstructionPayables · last filed 2023-11-08
- Adicet Bio, Inc. increase (decrease) in construction payables for the quarter ending 2023-09-30 was $1.10M.
- Adicet Bio, Inc. increase (decrease) in construction payables for the quarter ending 2023-06-30 was $200.00K.
- Adicet Bio, Inc. increase (decrease) in construction payables for the quarter ending 2023-03-31 was $7.50M.
| Period end | Increase (Decrease) in Construction Payables 3 month | Increase (Decrease) in Construction Payables 6 month | Increase (Decrease) in Construction Payables 9 month |
|---|---|---|---|
| 2023-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.30M derived: sum of 2 quarters · filed 2023-11-08 | $8.80M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $7.70M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $7.50M 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |